Myota
- Company typePrivate
- Founded2014
- HeadquartersLondon, United Kingdom
- Headcount1–10
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
Myota firmographics
Firmographics- Name
- Myota
- Legal name
- Myota Limited
- Website
- https://hellomyota.com
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
Myota industry classification
Industry- Product category
- Prebiotic Supplements
- NAICS
- Food Manufacturing (311), Food (Health) Supplement Retailers (456191)
- SIC
- Food And Kindred Products (2000), Miscellaneous Food Preparations & Kindred Products (2090)
- akta.pro industry
- Probiotics & Digestive Health SupplementsConsumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Vitamins, Supplements & Sports Nutrition
Keywords
Where Myota is headquartered
LocationHeadquarters
- HQ city
- London
- HQ country
- United Kingdom
- HQ region
- Europe
Offices3 records
Markets served
Myota business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Marketing or Sales, Personnel, Supply Chain, Operations, Infrastructure
Revenue model
- Subscription Revenue: Monthly and quarterly subscription plans for fibre blend products with recurring billing. Subscribers receive free shipping and discounted rates compared to one-time purchases.
- One-time Product Sales: Single purchase options for fibre blends (1-month supply) and bundles (3-month packs) at regular pricing without subscription discounts.
- Bundle and Cross-sell Revenue: Bundled products combining fibre blends with prebiotic fibre bars at discounted package prices, offering savings versus individual purchases.
- Gift Cards: Digital gift cards sold in denominations of £45, £120, and £220 for gifting the product to others.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Gut Health fibre blend subscription - £37.50/month with 10% subscriber discount |
| Subscription | Monthly | Metabolic Health fibre blend subscription - £37.50/month with 10% subscriber discount |
| Subscription | Multi-year contract | 3-Month Gut Reset Trial - £1.08/day (approximately £97.50 for 90 servings) |
| Unit Pricing | Pay-as-you-go | Prebiotic Fibre Bars - £2 per bar or £41 for 15-bar box |
| Subscription | Pay-as-you-go | 1-Month Gut Health Bundle - £42.50 (15% off) |
| Subscription | Multi-year contract | 3-Month Metabolic Health Bundle - £147 (30% off, save £68) |
| One time/ perpetual license | Pay-as-you-go | Digital Gift Cards - £45, £120, £220 denominations |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels7 records
Myota product offering
Product offeringCore offering
Myota develops and sells patented prebiotic fibre blend supplements (Gut Health and Metabolic Health variants) along with prebiotic fibre bars and a gut microbiome test kit. The blends combine 5-8 plant-based fibres that ferment in the gut to produce short-chain fatty acids (SCFAs) and are clinically proven to improve digestive regularity, reduce blood sugar spikes by 28%, lower cholesterol, and support immune, heart, brain and metabolic health. Products are sold direct-to-consumer via subscriptions and one-time purchases on myotahealth.com, plus supplied as B2B ingredients to food and beverage companies.
Product overview
Myota is a gut health company offering scientifically-formulated prebiotic fibre supplements. The product portfolio consists of two core fibre blend powders (Gut Health and Metabolic Health) designed for different health goals, Prebiotic Fibre Bars for on-the-go consumption, a Gut Microbiome Test Kit that provides personalized recommendations, and Digital Gift Cards. All products are developed in partnership with MIT and Cambridge University researchers, featuring patented, clinically-proven fibre blend formulations that target the gut microbiome to produce short-chain fatty acids (SCFAs) for overall health benefits.
Differentiator
Problem solved
Functional benefit
Products and services
- Gut Health fibre blend A vegan, low FODMAP certified blend of 5 natural prebiotic fibres designed to restore balance in the gut, relieve digestive symptoms, reduce bloating, cramps, and irregularity. Clinically proven to improve gut health and regularity. Sold via subscription (£37.50/month) or one-time purchase.
- Metabolic Health fibre blend A vegetarian, gluten-free blend of 8 plant-based fibres formulated to support gut, heart, and brain health. Designed to reduce mid-afternoon energy slumps, cravings, and lack of focus. Sold via subscription (£37.50/month) or one-time purchase.
- Prebiotic Fibre Bars On-the-go snack bars with over 12g of natural plant-based fibres per bar (40% of recommended daily intake). Available in Apple & Cinnamon and Peanut Butter & Chocolate flavours. Certified gluten-free and vegan. Priced at £2 per bar or £41 for a 15-bar box.
- Gut Microbiome Test Kit A stool sample test kit that analyzes gut microbiome composition and fermentation capability to provide personalized fibre-rich food recommendations. Described as the first and only test that reveals how gut bacteria break down different types of fibre to produce SCFAs.
- Digital Gift Card Digital gift cards available in £45, £120, and £220 denominations, allowing recipients to purchase Myota fibre blends and related products.
Quantifiable outcome
- 28% reduction in blood sugar spikes when taking Myota with a meal
- +4 more outcomes
Companies that use Myota
Customer profileNamed customers2 records
Segments6 records
Ideal customer profiles2 records
Myota technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Myota partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core and minor.
- MIT (Massachusetts Institute of Technology)coreOver a decade of research conducted at MIT's labs. Products developed by scientists who conducted groundbreaking gut microbiome research at MIT. Dr. Thomas Gurry completed PhD research at MIT's Computational Biophysics Group and served as Postdoctoral researcher at MIT Center for Microbiome Informatics and Therapeutics.
- Cambridge UniversitycoreResearch partnership for microbiome and fibre fermentation research. Listed as a research partner on the Myota website alongside MIT.
- University of GenevacoreAcademic research partnership where Dr. Thomas Gurry served as Senior Research Associate. Research on fibre fermentation by the gut microbiome conducted in collaboration with the university.
- King's College LondoncoreResearch partnership with Dr. Caitlin Hall completing PhD in Gut-Brain Axis Microbiology at this institution. Partnership for gut microbiome and mental health research.
- NHS (National Health Service)coreClinical trials conducted in partnership with NHS trusts for Type 2 diabetes research and pilot studies to treat IBS. Products trusted by NHS clinicians, demonstrating clinical credibility and regulatory acceptance.
- QIMR Berghofer (Medical Research Institute)minorDr. Caitlin Hall conducted PhD research in Gut-Brain Axis Microbiology at QIMR Berghofer in Australia, establishing an academic research connection.
- Aiven Partners LLCminorDr. Thomas Gurry serves as Consultant at Aiven Partners LLC alongside his role at Myota, representing an industry advisory connection.
Scale indicators9 records
Recent moves5 records
Expansion highlights6 records
Myota competitors and assessment
Company assessmentDirect peers
- Seed Health: US-based DTC microbiome company selling synbiotic (probiotic + prebiotic) supplements with a science-led brand narrative. Directly comparable to Myota in the consumer gut-health subscription category with overlapping target customers and clinician-endorsed positioning.
- Pendulum: DTC microbiome company focused on metabolic health (blood sugar, glucose control) using patented probiotic strains. Comparable to Myota in combining clinical evidence, patented formulations, and direct-to-consumer subscription distribution targeting the metabolic/gut-health overlap.
- ZOE: Personalised nutrition company offering gut microbiome testing combined with food and supplement recommendations. Directly comparable to Myota's combination of microbiome test kit, personalised recommendations, and DTC subscription model.
- Ritual: Premium DTC vitamins and supplements brand positioned around traceability, clinical evidence, and minimal-ingredient formulations. Comparable to Myota in the science-backed, subscription-based DTC supplement category targeting health-conscious consumers.
- Bio-Kult: UK-based probiotic supplement brand with live bacteria formulations targeting gut health, IBS, and digestive issues. Comparable to Myota as a UK-headquartered, science-supported gut-health brand competing for the same UK consumer and pharmacy channel.
- Optibac Probiotics: UK probiotic specialist offering strain-specific supplements for gut, IBS, and immune health with practitioner endorsements. Comparable to Myota in clinical positioning, UK distribution, and use of healthcare professional referrals to drive consumer demand.
Broad incumbents
- AG1 (Athletic Greens): Larger and more established DTC daily-nutrition brand with a comprehensive greens/supplement formulation. Comparable to Myota as a science-led DTC nutrition subscription at higher scale and broader scope (full-spectrum supplement vs. targeted prebiotic).
- BioGaia: Swedish probiotic supplement company with clinically documented Lactobacillus strains sold via healthcare professionals and OTC. Comparable to Myota in clinically validated microbiome products, though broader in scope (probiotics not prebiotics) and B2B/B2C hybrid.
Others
- Tate & Lyle: Global B2B food ingredient supplier with a significant portfolio of soluble fibres (including prebiotic fibres such as FOS and polydextrose). Comparable to Myota as a B2B supplier of prebiotic fibre ingredients into food and beverage manufacturers.
- BENEO: Südzucker subsidiary specialising in functional food ingredients including inulin, FOS, and other prebiotic fibres. Comparable to Myota as a B2B ingredient provider of the same fibre categories (FOS, inulin) that form the core of Myota's patented blends.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Myota social profiles
Digital presenceMyota compliance and trust
Trust signalCompliance6 records
Myota financial estimates
Financial estimateRevenue estimate
Valuation estimate
Myota leadership team
Management profileNumber of profiles
Profiles2 records
Myota funding detail
Funding detailFunding overview
Funding rounds2 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Myota M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Myota
What does Myota do?
Myota develops and sells patented prebiotic fibre blend supplements (Gut Health and Metabolic Health variants) along with prebiotic fibre bars and a gut microbiome test kit. The blends combine 5-8 plant-based fibres that ferment in the gut to produce short-chain fatty acids (SCFAs) and are clinically proven to improve digestive regularity, reduce blood sugar spikes by 28%, lower cholesterol, and support immune, heart, brain and metabolic health. Products are sold direct-to-consumer via subscriptions and one-time purchases on myotahealth.com, plus supplied as B2B ingredients to food and beverage companies.
Is Myota a public or private company?
Myota is a private company. It is classified as venture growth investor backed and is currently operating.
When was Myota founded?
Myota was founded in 2014. It employs 1 to 10 people.
Where is Myota based?
Myota is headquartered in London, United Kingdom, in the Europe region.
How does Myota make money?
Four revenue lines are on record. Subscription Revenue is the primary driver. The others are one-time Product Sales, bundle and Cross-sell Revenue and gift Cards.
Who are Myota's main competitors?
Direct peers on record are Seed Health, Pendulum, ZOE, Ritual, Bio-Kult and Optibac Probiotics. Broad incumbents are AG1 (Athletic Greens) and BioGaia. Others are Tate & Lyle and BENEO.
Does Myota have an API?
No public API is recorded for Myota.
What industry is Myota in?
Myota's product category is Prebiotic Supplements. Its primary akta.pro industry code is CRADAGAF, Probiotics & Digestive Health Supplements. Its NAICS code is 311 and its SIC code is 2000.